MaxCyte, Inc., a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics, ...

The aging and failure of cells that occurs when the liver is damaged can spread to other organs, suggests a new study in mice ...

One of the few bright spots in Boston’s life-science lab space market this year has dimmed.

The cell therapy biotech had been buoyed by a $3 billion biobucks partnership with Genentech, a deal the Roche subsidiary ...

Agentic AI has the potential to reshape not just healthcare, but the very foundations of biological research. By allowing ...

Researchers at ETH Zurich combined two CRISPR-Cas methods to decipher how mutations in a cell’s genome affect its function.

which are the precursors of the adult cells. In a recent article published in PLOS Biology, a team led by researchers at ...

Researchers at the Centre for Genomic Regulation (CRG) reveal that metabolic enzymes known for their roles in energy production and nucleotide synthesis are taking on unexpected "second jobs" within ...

Researchers reveal that metabolic enzymes known for their roles in energy production and nucleotide synthesis are taking on unexpected 'second jobs' within the nucleus, orchestrating critical ...

BioSpace takes a look at the headlines across a heavy earnings week for biotechs, checking in on Allogene, Rapport and more.

In recent years, scientists have created a range of new methods based on CRISPR-Cas technology for precisely editing the ...

Metabolic enzymes, typically associated with energy production, are now discovered to also play essential roles in the nucleus, such as orchestrating cell division and DNA repair. This breakthrough, ...